"Multiple Sclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Descriptor ID |
D009103
|
| MeSH Number(s) |
C10.114.375.500 C10.314.350.500 C20.111.258.250.500
|
| Concept/Terms |
Multiple Sclerosis- Multiple Sclerosis
- Sclerosis, Multiple
- Sclerosis, Disseminated
- Disseminated Sclerosis
- MS (Multiple Sclerosis)
|
Below are MeSH descriptors whose meaning is more general than "Multiple Sclerosis".
Below are MeSH descriptors whose meaning is more specific than "Multiple Sclerosis".
This graph shows the total number of publications written about "Multiple Sclerosis" by people in this website by year, and whether "Multiple Sclerosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 3 | 2 | 5 |
| 1999 | 4 | 0 | 4 |
| 2000 | 4 | 2 | 6 |
| 2001 | 7 | 1 | 8 |
| 2002 | 8 | 1 | 9 |
| 2003 | 10 | 1 | 11 |
| 2004 | 9 | 0 | 9 |
| 2005 | 7 | 1 | 8 |
| 2006 | 1 | 0 | 1 |
| 2007 | 5 | 1 | 6 |
| 2008 | 6 | 0 | 6 |
| 2009 | 8 | 1 | 9 |
| 2010 | 8 | 0 | 8 |
| 2011 | 9 | 1 | 10 |
| 2012 | 5 | 1 | 6 |
| 2013 | 9 | 1 | 10 |
| 2014 | 10 | 1 | 11 |
| 2015 | 6 | 1 | 7 |
| 2016 | 6 | 0 | 6 |
| 2017 | 13 | 2 | 15 |
| 2018 | 6 | 3 | 9 |
| 2019 | 14 | 1 | 15 |
| 2020 | 18 | 2 | 20 |
| 2021 | 15 | 1 | 16 |
| 2022 | 18 | 0 | 18 |
| 2023 | 19 | 0 | 19 |
| 2024 | 18 | 3 | 21 |
| 2025 | 17 | 0 | 17 |
| 2026 | 8 | 1 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multiple Sclerosis" by people in Profiles.
-
Adaptation of the Transition Readiness Assessment Questionnaire for Pediatric-Onset Multiple Sclerosis: Protocol for a User-Centered Design Approach. JMIR Res Protoc. 2026 06 24; 15:e91763.
-
Patient-Centered, Theory-Based, Online Intervention to Promote a Physically Active Lifestyle for People With Multiple Sclerosis: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 07 17; 14:e66091.
-
Very-long-chain fatty acids induce glial-derived sphingosine-1-phosphate synthesis, secretion, and neuroinflammation. Cell Metab. 2023 05 02; 35(5):855-874.e5.
-
Investigation of differentially expressed genes and dysregulated pathways involved in multiple sclerosis. Adv Protein Chem Struct Biol. 2022; 131:235-259.
-
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults. JAMA Netw Open. 2021 02 01; 4(2):e2036321.
-
The Daam2-VHL-Nedd4 axis governs developmental and regenerative oligodendrocyte differentiation. Genes Dev. 2020 09 01; 34(17-18):1177-1189.
-
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. Nat Immunol. 2020 05; 21(5):513-524.
-
Nuclear factor I-A regulates diverse reactive astrocyte responses after CNS injury. J Clin Invest. 2019 10 01; 129(10):4408-4418.
-
Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler. 2018 12; 24(14):1825-1834.
-
Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord. 2017 Nov; 18:164-169.